5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
The market is segmented by Product (Drugs and Devices), Gender, and Geography
The Asia-Pacific Contraceptive drugs and devices market is anticipated to grow with a CAGR of 6.39%, during the forecast period. The major factors attributing to the growth of the Asia-Pacific contraceptive drugs and devices market include the necessity to avoid unwanted pregnancies and their complications. The need to avoid unwanted pregnancies, especially in the teenage women, is one of the major drivers for this market. It is also observed that more than half of the women identify non-contraceptive health benefits, such as treatment for excessive menstrual bleeding, menstrual pain, and acne, as reasons for use. This is also one of the factors contributing to the growth of the market. The other factors helping the growth of the contraceptives market are the increasing incidence of STDs and the rapid increase in population in the region.
In basic terms, contraceptives refer to a set of devices, methods, medications, techniques that are used to control births. The use of contraceptive pills, hormonal IUD, copper IUD, condoms, diaphragm, injections, and cervical cap are some commonly used contraceptive methods.
Report scope can be customized per your requirements. Click here.
Oral contraceptive pills are seen as the easiest method of contraception in the industry. They act by prohibiting implantation within the uterus if taken within 2-3 days of having unsafe sexual contact. The simplicity of their usage makes them an ideal contraceptive in the market. These are easily marketed across the region by companies and thus easily consumed by a large section of the population, regionally. These factors are expected to contribute to the growth of the market during the forecast period.
To understand key trends, Download Sample Report
The Asia-Pacific contraceptive market is competitive and consists of several players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions and joint ventures with the other companies to consolidate their market positions across the region. Some of the companies which are currently dominating the market are Bayer AG, Pfizer Inc., Merck & Co., Inc., CooperSurgical Inc., and Allergan PLC.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Incidence of the STDs
4.2.2 Increasing Rate of Unintended Pregnancies
4.2.3 Rise in Government Initiatives
4.3 Market Restraints
4.3.1 High Cost of Devices and Treatment
4.3.2 Side Effects Associated with the Use of Contraceptive Drugs and Devices
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Products
5.1.1 By Drugs
18.104.22.168 Oral Contraceptives
22.214.171.124 Topical Contraceptives
126.96.36.199 Contraceptive Injectable
5.1.2 By Device
188.8.131.52 Cervical Caps
184.108.40.206 Vaginal Rings
220.127.116.11 Other Devices
5.2 By Gender
18.104.22.168 South korea
22.214.171.124 Rest of Asia-Pacific
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Bayer AG
6.1.2 Pfizer Inc.
6.1.3 Merck & Co. Inc.
6.1.4 CooperSurgical, Inc.
6.1.5 Allergan PLC
6.1.6 Johnson & Johnson, Ltd
6.1.7 Lupin Pharmaceuticals, Ltd
6.1.8 Mylan Laboratories
6.1.9 Church & Dwight, Co. Inc
6.1.10 The Female Health Company
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments